About Cyclopharm
Cyclopharm is a company based in Sydney (Australia) founded in 1986.. The company has 95 employees as of December 31, 2024. Cyclopharm offers products and services including Technegas. Cyclopharm operates in a competitive market with competitors including Body Vision Medical, Perfint Healthcare, Positrigo, Polarean Imaging and Mobius Imaging, among others.
- Headquarter Sydney, Australia
- Employees 95 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cyclopharm Limited
-
Annual Revenue
$17.08 M (USD)4.68as on Dec 31, 2024
-
Net Profit
$-8.18 M (USD)-180.75as on Dec 31, 2024
-
EBITDA
$-8.08 M (USD)-43.61as on Dec 31, 2024
-
Latest Funding Round
$9.81 M (USD), Post-IPO
Feb 04, 2026
-
Investors
-
Employee Count
95
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cyclopharm
Cyclopharm is a publicly listed company on the ASX with ticker symbol CYC in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cyclopharm
Cyclopharm offers a comprehensive portfolio of products and services, including Technegas. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for pulmonary diagnostic imaging and patient management.
Funding Insights of Cyclopharm
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $9.8M
-
First Round
First Round
(04 Feb 2026)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2026 | Amount | Post-IPO - Cyclopharm | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Cyclopharm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cyclopharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cyclopharm Comparisons
Competitors of Cyclopharm
Cyclopharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Body Vision Medical, Perfint Healthcare, Positrigo, Polarean Imaging and Mobius Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Image-based intra-body navigation technology for medical diagnostics is developed.
|
|
| domain | founded_year | HQ Location |
Solutions for image-guided interventional procedures are developed.
|
|
| domain | founded_year | HQ Location |
A compact brain PET scanner for dementia monitoring is offered.
|
|
| domain | founded_year | HQ Location |
Noble gas polarizers for hyperpolarized pulmonary MRI are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a CT medical imaging system
|
|
| domain | founded_year | HQ Location |
Portable CT scanners are developed and marketed for medical use.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cyclopharm
Frequently Asked Questions about Cyclopharm
When was Cyclopharm founded?
Cyclopharm was founded in 1986 and raised its 1st funding round 40 years after it was founded.
Where is Cyclopharm located?
Cyclopharm is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Who is the current CEO of Cyclopharm?
James McBrayer is the current CEO of Cyclopharm.
How many employees does Cyclopharm have?
As of Dec 31, 2024, the latest employee count at Cyclopharm is 95.
What is the annual revenue of Cyclopharm?
Annual revenue of Cyclopharm is $17.08M as on Dec 31, 2024.
What does Cyclopharm do?
Cyclopharm was founded in 1986 in Sydney, Australia, and operates in the healthcare sector focused on diagnostic imaging. Radiopharmaceuticals and medical devices are developed by the company, including TECHNEGAS, a radiolabelled carbon substance produced from Technetium-99m. This gaseous agent is inhaled by patients and detected via nuclear medicine tomography to visualize lung alveolar spaces. Operations center on advancing lung diagnostic technologies for clinical use.
Who are the top competitors of Cyclopharm?
Cyclopharm's top competitors include Positrigo, Polarean Imaging and Neurologica.
What products or services does Cyclopharm offer?
Cyclopharm offers Technegas.
Is Cyclopharm publicly traded?
Yes, Cyclopharm is publicly traded on ASX under the ticker symbol CYC.
What is Cyclopharm's ticker symbol?
The ticker symbol of Cyclopharm is CYC on ASX.